Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-07-16

Clinical Trial Update: Serum Preptin and Amylin Levels in Polycystic Ovary Syndrome Patients

View source ↗

Summary

A completed clinical trial from Recep Tayyip Erdogan University examines serum preptin and amylin levels in women with polycystic ovary syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Recep Tayyip Erdogan University Training and Research Hospital | Conditions: Polycystic Ovary Syndrome | Status: COMPLETED